Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Carcinoma This cohort study evaluates the accuracy of sentinel lymph node biopsy in head and neck Merkel cell carcinoma to inform risk stratification before and after the procedure.

Among patients with head and neck #MerkelCellCarcinoma, sentinel lymph node biopsy identified occult nodal disease in more than half of cases but showed reduced accuracy compared to other sites. ja.ma/4tTDTxv

Congratulations to Chiara Mazziotta, PhD, of Dana-Farber Cancer Institute a NETRF Mentored Research Grantee for her research on Merkel cell carcinoma, a rare neuroendocrine skin cancer.

Learn more about Dr. Mazziotta’s research: https://ow.ly/g2BP50YuXyW

#NETRFGrantee #Merkelcellcarcinoma

Earlier this month at CSI Science Exchange, we welcomed Dr. Norbert Tay for a research sharing session titled “Understanding Merkel Cell Carcinoma with Spatial Transcriptomics.” He is a Postdoctoral Fellow at @uofmichigan.bsky.social.

#cancerresearch #spatialtranscriptomics #merkelcellcarcinoma

JAMA Otolaryngology-Head & Neck Surgery article, "Accuracy of Sentinel Lymph Node Biopsy to Predict Nodal Metastasis in Head and Neck Merkel Cell Carcinoma" by Stephanie Y. Wang, Gavin Turner, Karla L. Valdes-Morales et al., published January 29, 2026.

Among patients with head and neck #MerkelCellCarcinoma, sentinel lymph node biopsy identified occult nodal disease in more than half of cases but showed reduced accuracy compared to other sites.

ja.ma/4qRv0Te

Among patients with head and neck #MerkelCellCarcinoma, sentinel lymph node biopsy identified occult nodal disease in more than half of cases but showed reduced accuracy compared to other sites. ja.ma/4sRUlhe

Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer A new clinical trials shows that pembrolizumab, a drug that utilizes the body’s immune system to target and eliminate cancer cells, appeared to reduce the risk of distant metastases for an aggressive ...

#FindingsFriday: ICYMI, at #ESMO25 Dr. Janice Mehnert @nyulangone.bsky.social presented results from the STAMP trial, showing that giving pembro after surgery may help prevent #MerkelCellCarcinoma from spreading to distant organs. Promising progress for this rare #SkinCancer! More: bit.ly/49uM4sa

Press Release: Immunotherapy after surgery shows potential in preventing the spread of aggressive skin cancer A new clinical trials shows that pembrolizumab, a drug that utilizes the body’s immune system to target and eliminate cancer cells, appeared to reduce the risk of distant metastases for an aggressive ...

#Immunotherapy after surgery shows potential in preventing spread of aggressive skin cancer. STAMP (EA6174) results at #ESMO25 by Dr. Janice Mehnert of NYU Langone’s Perlmutter Cancer Center. Largest study to date to evaluate pembrolizumab as adjuvant therapy for #MerkelCellCarcinoma bit.ly/4hgQrJg

📢🔬 Join Our Team! #MC3Institute is hiring 2 paid, full-time Clinical Research Fellows! Help improve #MerkelcellCarcinoma care thru patient support, clinical trials, & research, under the mentorship of Dr. Paul Nghiem. @fredhutch.org

Apply 👉 mc3institute.uw.edu/apply-mc3-clinical-research-fellowship

✨Poster Spotlight ✨

Tomas Bencomo, grad student in the #NghiemLab, shares his poster from last week’s 2025 Merkel CELLebration, on #spatialtranscriptomics which helps identify why some patients respond to #immunotherapy & others don’t.

#merkelcellcarcinoma #cancerresearch

👏 Congratulations to Dr. Bhatia on this well-earned recognition! Your work continues to fuel progress in the fight against #Merkelcellcarcinoma — and we’re proud to be your partners.

✨ Poster Spotlight ✨
Kate Biese shares her poster from last week’s #MerkelCELLebration on this summer’s @fredhutch.org @obliteride.bsky.social! 🚴‍♂️

⏳ 1 week left to support our team—Donations accepted thru 9/30. tinyurl.com/obiteride-mc3

#Obliteride #CureCancerFaster #merkelcellcarcinoma

Congrats to Dr. @bhatia-s-md.bsky.social on being named the inaugural holder of the Lyn and Daniel Lerner Endowed Chair in #MerkelCellCarcinoma at Fred Hutch. Read more: https://bit.ly/3IwHQFp

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

🔦 buff.ly/1ZZBtJh

🖊️ @DrLitvinov

#Merkelcellcarcinoma

🗞️ Fresh off the press! #MC3Memos newsletter vol 2 is here—packed w/ stories, latest advancements, & opportunities within the Merkel Cell Carcinoma (MC3) Institute.

📰 mc3institute.uw.edu/news/mc3-memos-vol-2

@fredhutch.bsky.social @uwmedicine.bsky.social
#merkelcellcarcinoma #cancerresearch

📌During #SkinCancerAwarenessMonth, let’s put #MerkelCellCarcinoma (MCC) in the spotlight.
👉Merkel cells are a special type of cells and contain substances that may act as hormones – MCC is considered NEC.
✅Learn about MCC in 11 languages: incalliance.org/net-info-pac...
#LetsTalkAboutNETs

Multidisciplinary Collaboration and Immunotherapy Help Overcome Treatment Challenges in MCC
#MerkelCellCarcinoma @roswellpark.bsky.social
www.onclive.com/view/multidi...

One of the nastiest skin tumours. This one in a vessel enroute to destroy the respiratory membrane diffusion gradient.
#MerkelCellCarcinoma
#pathology
#dermatology
#PathSky
👿

Exploring the latest advancements in #MerkelCellCarcinomatreatment. The fight against this #rarecancer is progressing thanks to cutting-edge research and innovative therapies. Stay informed, stay strong. 💪 Visit: rb.gy/6dp9ix #MerkelCellCarcinoma #CancerResearch #HealthInnovation